From Bench to Bedside: Blindness

Researchers in the U.S. are building on the success of a clinical trial overseas and are testing a new therapy designed to halt the progression of choroideremia, and perhaps even reverse some of the damage.

Featured Videos

How to Prevent Alzheimer's

Juvenile Arthritis Awareness Month

Let's Play: The Last of Us Part II

Isolamento social pede atenção à saúde mental das crianças